ILA 285.5
(0.78%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -15.68 Million | -45.1 Million | -23.74 Million | -3.82 Million | -3.21 Million | -14.2 Million |
Net Income | -12.99 Million | -11.72 Million | -7.21 Million | -5.28 Million | -2.58 Million | 4.41 Million |
Depreciation & Amortization | 586 Thousand | 899 Thousand | 813 Thousand | 655 Thousand | 589 Thousand | 233 Thousand |
Deferred income taxes | -14.31 Million | - | - | - | - | - |
Stock-based compensation | 92 Thousand | - | - | - | - | - |
Change in working capital | 700 Thousand | -21.43 Million | 359 Thousand | 10.5 Million | 7.42 Million | -575 Thousand |
Other non-cash items | 10.24 Million | -12.84 Million | -17.7 Million | 4.97 Million | -8.63 Million | -18.27 Million |
Investing Cash Flow | 2.33 Million | 7.36 Million | -12.45 Million | 28.22 Million | -13.37 Million | 1.12 Million |
Investments in PPE | -11 Thousand | -194 Thousand | -20 Thousand | -22 Thousand | -97 Thousand | -179 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 2.34 Million | 7.56 Million | -12.43 Million | 28.25 Million | -13.27 Million | 1.3 Million |
Financing Cash Flow | -5.28 Million | 1.88 Million | 90.25 Million | -25.78 Million | 25.95 Million | 12.89 Million |
Debt repayment | -65.5 Million | -19.37 Million | -15.01 Million | -12.01 Million | -13.93 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 10.77 Million | - | - | - | - | - |
Other Financing Activities | 39.62 Million | 1.88 Million | 90.25 Million | -13.77 Million | 12.01 Million | 12.89 Million |
Accounts receivables | 9.97 Million | 4.81 Million | -11.32 Million | 17.11 Million | 21.36 Million | -9.8 Million |
Accounts payables | -9.97 Million | - | - | - | - | - |
Inventory | -11.54 Million | -11.27 Million | 26.96 Million | -527 Thousand | -5.97 Million | 10.1 Million |
Other working capital | 12.24 Million | -14.97 Million | -15.28 Million | -6.08 Million | -7.97 Million | -870 Thousand |
Cash at beginning of period | 28.48 Million | 64.33 Million | 10.28 Million | 11.67 Million | 2.3 Million | 2.49 Million |
Cash at end of period | 9.84 Million | 28.48 Million | 64.33 Million | 10.28 Million | 11.67 Million | 2.3 Million |
Capital Expenditure | -11 Thousand | -194 Thousand | -20 Thousand | -22 Thousand | -97 Thousand | -179 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -18.64 Million | -35.85 Million | 54.04 Million | -1.38 Million | 9.36 Million | -186 Thousand |
Free Cash Flow | -15.7 Million | -45.3 Million | -23.76 Million | -3.84 Million | -3.3 Million | -14.38 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -3.4 Million | 4.84 Million | -3.22 Million | -12.99 Million | -3.06 Million | -3.04 Million |
Depreciation & Amortization | 70 Thousand | 100 Thousand | 100 Thousand | 586 Thousand | 112 Thousand | 149 Thousand |
Deferred income taxes | - | - | - | -14.31 Million | - | 365 Thousand |
Stock-based compensation | 17 Thousand | 18 Thousand | 18 Thousand | 92 Thousand | 18 Thousand | 18 Thousand |
Change in working capital | 4.51 Million | -14.33 Million | -5.69 Million | 700 Thousand | 1.74 Million | 4.24 Million |
Other non-cash items | 2.66 Million | 2.7 Million | 2.03 Million | 10.24 Million | -1.96 Million | 2.46 Million |
Investing Cash Flow | -230 Thousand | 1.27 Million | 6.06 Million | 2.33 Million | 7.35 Million | -8.65 Million |
Investments in PPE | - | - | - | -11 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 570 Thousand | 1.59 Million | 6.06 Million | 2.34 Million | 7.35 Million | -5.7 Million |
Financing Cash Flow | -2.72 Million | 1.64 Million | -355 Thousand | -5.28 Million | -7.38 Million | 3.82 Million |
Debt repayment | -2.59 Million | -1.81 Million | -25.69 Million | -65.5 Million | -18.88 Million | -3.98 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 10.77 Million | - | - |
Other Financing Activities | -2.59 Million | 1.81 Million | -355 Thousand | 39.62 Million | 11.5 Million | 3.98 Million |
Accounts receivables | -3.87 Million | -190 Thousand | 717 Thousand | 9.97 Million | 3.96 Million | 5.86 Million |
Accounts payables | - | - | - | -9.97 Million | - | - |
Inventory | 5.88 Million | -909 Thousand | -2.75 Million | -11.54 Million | -199 Thousand | -5.79 Million |
Other working capital | 4.4 Million | -11.23 Million | -3.64 Million | 12.24 Million | -2.02 Million | 1.53 Million |
Cash at beginning of period | 6.32 Million | 9.84 Million | 10.88 Million | 28.48 Million | 14.06 Million | 17.22 Million |
Cash at end of period | 5.27 Million | 6.32 Million | 9.84 Million | 9.84 Million | 10.88 Million | 14.06 Million |
Capital Expenditure | - | - | - | -11 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.05 Million | -3.51 Million | -1.04 Million | -18.64 Million | -3.17 Million | -3.16 Million |
Free Cash Flow | 1.9 Million | -6.44 Million | -6.76 Million | -15.7 Million | -3.14 Million | 1.67 Million |
3266
ZWIPE
SCLP
ACROW
688070
BIOFILCHEM